• We are sorry, but NCBI web applications do not support your browser and may not function properly. More information
Logo of gutGutView this articleSubmit a manuscriptReceive email alertsContact usBMJ
Gut. Sep 1999; 45(Suppl 2): II48–II54.
PMCID: PMC1766688

Functional disorders of the biliary tract and pancreas

Abstract

The term "dysfunction" defines the motor disorders of the gall bladder and the sphincter of Oddi (SO) without note of the potential etiologic factors for the difficulty to differentiate purely functional alterations from subtle structural changes. Dysfunction of the gall bladder and/or SO produces similar patterns of biliopancreatic pain and SO dysfunction may occur in the presence of the gall bladder. The symptom-based diagnostic criteria of gall bladder and SO dysfunction are episodes of severe steady pain located in the epigastrium and right upper abdominal quadrant which last at least 30 minutes. Gall bladder and SO dysfunctions can cause significant clinical symptoms but do not explain many instances of biliopancreatic type of pain. The syndrome of functional abdominal pain should be differentiated from gall bladder and SO dysfunction. In the diagnostic workup, invasive investigations should be performed only in the presence of compelling clinical evidence and after non-invasive testing has yielded negative findings. Gall bladder dysfunction is suspected when laboratory, ultrasonographic, and microscopic bile examination have excluded the presence of gallstones and other structural abnormalities. The finding of decreased gall bladder emptying at cholecystokinin-cholescintigraphy is the only objective characteristic of gall bladder dysfunction. Symptomatic manifestation of SO dysfunction may be accompanied by features of biliary obstruction (biliary-type SO dysfunction) or significant elevation of pancreatic enzymes and pancreatitis (pancreatic-type SO dysfunction). Biliary-type SO dysfunction occurs more frequently in postcholecystectomy patients who are categorized into three types. Types I and II, but not type III, have biochemical and cholangiographic features of biliary obstruction. Pancreatic-type SO dysfunction is less well classified into types. When non-invasive investigations and endoscopic retrograde cholangiopanreatography show no structural abnormality, manometry of both biliary and pancreatic sphincter may be considered.


Keywords: biliary tract disease; sphincter of Oddi dysfunction; gallstone disease; pancreatitis; endoscopic retrograde cholangiopancreatography; cholescintigraphy; endoscopic ultrasonography; cholecystokinin; magnetic resonance cholangiopancreatography; Rome II

Full Text

The Full Text of this article is available as a PDF (95K).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Stolk MF, van Erpecum KJ, Smout AJ, Akkermans LM, Jansen JB, Lamers CB, Peeters TL, vanBerge-Henegouwen GP. Motor cycles with phase III in antrum are associated with high motilin levels and prolonged gallbladder emptying. Am J Physiol. 1993 Apr;264(4 Pt 1):G596–G600. [PubMed]
  • Takahashi T, May D, Owyang C. Cholinergic dependence of gallbladder response to cholecystokinin in the guinea pig in vivo. Am J Physiol. 1991 Oct;261(4 Pt 1):G565–G569. [PubMed]
  • Pauletzki JG, Sharkey KA, Davison JS, Bomzon A, Shaffer EA. Involvement of L-arginine-nitric oxide pathways in neural relaxation of the sphincter of Oddi. Eur J Pharmacol. 1993 Mar 2;232(2-3):263–270. [PubMed]
  • Pomeranz IS, Shaffer EA. Abnormal gallbladder emptying in a subgroup of patients with gallstones. Gastroenterology. 1985 Mar;88(3):787–791. [PubMed]
  • Westlake PJ, Hershfield NB, Kelly JK, Kloiber R, Lui R, Sutherland LR, Shaffer EA. Chronic right upper quadrant pain without gallstones: does HIDA scan predict outcome after cholecystectomy? Am J Gastroenterol. 1990 Aug;85(8):986–990. [PubMed]
  • Cervero F, Laird JM. From acute to chronic pain: mechanisms and hypotheses. Prog Brain Res. 1996;110:3–15. [PubMed]
  • Gracie WA, Ransohoff DF. The natural history of silent gallstones: the innocent gallstone is not a myth. N Engl J Med. 1982 Sep 23;307(13):798–800. [PubMed]
  • Kraag N, Thijs C, Knipschild P. Dyspepsia--how noisy are gallstones? A meta-analysis of epidemiologic studies of biliary pain, dyspeptic symptoms, and food intolerance. Scand J Gastroenterol. 1995 May;30(5):411–421. [PubMed]
  • Barbara L, Sama C, Morselli Labate AM, Taroni F, Rusticali AG, Festi D, Sapio C, Roda E, Banterle C, Puci A, et al. A population study on the prevalence of gallstone disease: the Sirmione Study. Hepatology. 1987 Sep-Oct;7(5):913–917. [PubMed]
  • JUNIPER K, Jr, BURSON EN., Jr Biliary tract studies. II. The significance of biliary crystals. Gastroenterology. 1957 Feb;32(2):175–211. [PubMed]
  • Buscail L, Escourrou J, Delvaux M, Guimbaud R, Nicolet T, Frexinos J, Ribet A. Microscopic examination of bile directly collected during endoscopic cannulation of the papilla. Utility in patients with suspected microlithiasis. Dig Dis Sci. 1992 Jan;37(1):116–120. [PubMed]
  • Yap L, Wycherley AG, Morphett AD, Toouli J. Acalculous biliary pain: cholecystectomy alleviates symptoms in patients with abnormal cholescintigraphy. Gastroenterology. 1991 Sep;101(3):786–793. [PubMed]
  • Barr RG, Agnesi JN, Schaub CR. Acalculous gallbladder disease: US evaluation after slow-infusion cholecystokinin stimulation in symptomatic and asymptomatic adults. Radiology. 1997 Jul;204(1):105–111. [PubMed]
  • Xu QW, Shaffer EA. Cisapride improves gallbladder contractility and bile lipid composition in an animal model of gallstone disease. Gastroenterology. 1993 Oct;105(4):1184–1191. [PubMed]
  • Sylwestrowicz TA, Shaffer EA. Gallbladder function during gallstone dissolution. Effect of bile acid therapy in patients with gallstones. Gastroenterology. 1988 Sep;95(3):740–748. [PubMed]
  • Thornell E, Svanvik J. Pathophysiological aspects on biliary pain. Scand J Urol Nephrol Suppl. 1983;75:45–46. [PubMed]
  • Geenen JE, Hogan WJ, Dodds WJ, Toouli J, Venu RP. The efficacy of endoscopic sphincterotomy after cholecystectomy in patients with sphincter-of-Oddi dysfunction. N Engl J Med. 1989 Jan 12;320(2):82–87. [PubMed]
  • Drossman DA, Li Z, Andruzzi E, Temple RD, Talley NJ, Thompson WG, Whitehead WE, Janssens J, Funch-Jensen P, Corazziari E, et al. U.S. householder survey of functional gastrointestinal disorders. Prevalence, sociodemography, and health impact. Dig Dis Sci. 1993 Sep;38(9):1569–1580. [PubMed]
  • Bar-Meir S, Halpern Z, Bardan E, Gilat T. Frequency of papillary dysfunction among cholecystectomized patients. Hepatology. 1984 Mar-Apr;4(2):328–330. [PubMed]
  • Sherman S, Troiano FP, Hawes RH, O'Connor KW, Lehman GA. Frequency of abnormal sphincter of Oddi manometry compared with the clinical suspicion of sphincter of Oddi dysfunction. Am J Gastroenterol. 1991 May;86(5):586–590. [PubMed]
  • Steinberg WM. Sphincter of Oddi dysfunction: a clinical controversy. Gastroenterology. 1988 Nov;95(5):1409–1415. [PubMed]
  • Hunt DR, Scott AJ. Changes in bile duct diameter after cholecystectomy: a 5-year prospective study. Gastroenterology. 1989 Dec;97(6):1485–1488. [PubMed]
  • Shaffer EA, Hershfield NB, Logan K, Kloiber R. Cholescintigraphic detection of functional obstruction of the sphincter of Oddi. Effect of papillotomy. Gastroenterology. 1986 Mar;90(3):728–733. [PubMed]
  • Corazziari E, Cicala M, Habib FI, Scopinaro F, Fiocca F, Pallotta N, Viscardi A, Vignoni A, Torsoli A. Hepatoduodenal bile transit in cholecystectomized subjects. Relationship with sphincter of Oddi function and diagnostic value. Dig Dis Sci. 1994 Sep;39(9):1985–1993. [PubMed]
  • Guelrud M, Mendoza S, Rossiter G, Villegas MI. Sphincter of Oddi manometry in healthy volunteers. Dig Dis Sci. 1990 Jan;35(1):38–46. [PubMed]
  • Toouli J, Roberts-Thomson IC, Dent J, Lee J. Manometric disorders in patients with suspected sphincter of Oddi dysfunction. Gastroenterology. 1985 May;88(5 Pt 1):1243–1250. [PubMed]
  • Sand J, Nordback I, Koskinen M, Matikainen M, Lindholm TS. Nifedipine for suspected type II sphincter of Oddi dyskinesia. Am J Gastroenterol. 1993 Apr;88(4):530–535. [PubMed]
  • Bar-Meir S, Halpern Z, Bardan E. Nitrate therapy in a patient with papillary dysfunction. Am J Gastroenterol. 1983 Feb;78(2):94–95. [PubMed]
  • Pasricha PJ, Miskovsky EP, Kalloo AN. Intrasphincteric injection of botulinum toxin for suspected sphincter of Oddi dysfunction. Gut. 1994 Sep;35(9):1319–1321. [PMC free article] [PubMed]
  • Toouli J, Di Francesco V, Saccone G, Kollias J, Schloithe A, Shanks N. Division of the sphincter of Oddi for treatment of dysfunction associated with recurrent pancreatitis. Br J Surg. 1996 Sep;83(9):1205–1210. [PubMed]
  • Desautels SG, Slivka A, Hutson WR, Chun A, Mitrani C, DiLorenzo C, Wald A. Postcholecystectomy pain syndrome: pathophysiology of abdominal pain in sphincter of Oddi type III. Gastroenterology. 1999 Apr;116(4):900–905. [PubMed]

Articles from Gut are provided here courtesy of BMJ Group

Formats:

Related citations in PubMed

See reviews...See all...

Cited by other articles in PMC

See all...

Links

  • Cited in Books
    Cited in Books
    PubMed Central articles cited in books
  • MedGen
    MedGen
    Related information in MedGen
  • PubMed
    PubMed
    PubMed citations for these articles

Recent Activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...